Abstract
Can T cells be directly activated to de novo gene expression by gonadotropin-releasing hormone-II (GnRH-II), a unique 10-aminoacid neuropeptide conserved through 500 million years of evolution? GnRH-II, which has been identified in mammals1,2, shares 70% homology with the mammalian hypothalamic neurohormone GnRH (GnRH-I), the primary regulator of reproduction, but is encoded by a different gene3. Although both neuropeptides are produced mainly in brain, their localization1,2 and promoter regulation4,5 differ, suggestive of distinct functions. Indeed, GnRH-II barely affects reproduction1 and its role in mammalian physiology is unknown. We find here that human normal and leukemic T cells produce GnRH-II and GnRH-I. Further, exposure of normal or cancerous human or mouse T cells to GnRH-II or GnRH-I triggered de novo gene transcription and cell-surface expression of a 67-kD non-integrin laminin receptor that is involved in cellular adhesion and migration and in tumor invasion and metastasis. GnRH-II or GnRH-I also induced adhesion to laminin and chemotaxis toward SDF-1α, and augmented entry in vivo of metastatic T-lymphoma into the spleen and bone marrow. Homing of normal T cells into specific organs was reduced in mice lacking GnRH-I. A specific GnRH-I-receptor antagonist blocked GnRH-I- but not GnRH-II-induced effects, which is suggestive of signaling through distinct receptors. We suggest that GnRH-II and GnRH-I, secreted from nerves or autocrine or paracrine sources, interact directly with T cells and trigger gene transcription, adhesion, chemotaxis and homing to specific organs, which may be of clinical relevance.
Original language | English |
---|---|
Pages (from-to) | 1421-1426 |
Number of pages | 6 |
Journal | Nature Medicine |
Volume | 8 |
Issue number | 12 |
DOIs | |
State | Published - 1 Dec 2002 |
Externally published | Yes |
Bibliographical note
Funding Information:Acknowledgments We thank E. Flesher of the Sackler Faculty of Medicine, Tel Aviv University, for the EL-4 T-lymphoma cells and helpful discussions, and H. Otmi and R. Margalit for expert animal handling and surgery. This study was supported by grants from the Volkswagen-Stiftung Foundation and the Rochlin Foundation (to M.L.) and from the Israel Science Foundation (to Y.K).
Funding
Acknowledgments We thank E. Flesher of the Sackler Faculty of Medicine, Tel Aviv University, for the EL-4 T-lymphoma cells and helpful discussions, and H. Otmi and R. Margalit for expert animal handling and surgery. This study was supported by grants from the Volkswagen-Stiftung Foundation and the Rochlin Foundation (to M.L.) and from the Israel Science Foundation (to Y.K).
Funders | Funder number |
---|---|
Rochlin Foundation | |
Volkswagen-Stiftung Foundation | |
Israel Science Foundation |